Smith G H, Canning D A, Schulman S L, Snyder H M, Duckett J W
Department of Urology, Children's Hospital of Philadelphia, Pennsylvania, USA.
J Urol. 1996 May;155(5):1730-4.
We believe that primary valve ablation with observation is the preferred management for posterior urethral valves. However, debate continues as to the role of high diversion. We examined the long-term outcome of a large series of patients treated with primary valve ablation, and compared it to the outcome of high diversion and vesicostomy.
We reviewed the records of 100 patients treated with primary valve ablation (74%), vesicostomy (13%) or high diversion (9%) before 1985. Median followup was 11.2 years.
Overall 13% of our patients had end stage renal disease by age 15 years. Three patients initially treated with valve ablation and 3 initially treated with vesicostomy later underwent high diversion but none benefited from the secondary procedure. Four patients initially treated with valve ablation subsequently underwent vesicostomy but only 1 benefited. Bladder storage capacity was well preserved. Diurnal urinary continence developed in 46% of patients at age 10 years and only 1 remained incontinent after age 20 years. One patient with diversion who awaits transplantation had a small contracted bladder. Recent urodynamic studies in 10 cases of delayed urinary continence have not shown decreased bladder compliance or capacity. Kaplan-Meier analysis of outcomes of the different treatments indicated no statistical difference in patient age at end stage renal disease development. However, comparing the number of surgical procedures in the different treatment groups revealed a significant increase in the amount of surgery in infants with diversion. Our results were equivalent to those of the best published series, many of which strongly advocate high diversion.
By avoiding diversion in most cases bladder function is preserved and the need for bladder augmentation is decreased.
我们认为,对于后尿道瓣膜,首选的治疗方法是一期瓣膜消融并观察。然而,关于高位转流术的作用仍存在争议。我们研究了一大组接受一期瓣膜消融治疗患者的长期预后,并将其与高位转流术和膀胱造瘘术的预后进行比较。
我们回顾了1985年前接受一期瓣膜消融治疗(74%)、膀胱造瘘术(13%)或高位转流术(9%)的100例患者的记录。中位随访时间为11.2年。
总体而言,13%的患者在15岁时发展为终末期肾病。3例最初接受瓣膜消融治疗的患者和3例最初接受膀胱造瘘术的患者后来接受了高位转流术,但均未从二次手术中获益。4例最初接受瓣膜消融治疗的患者随后接受了膀胱造瘘术,但只有1例获益。膀胱储存容量得到良好保留。46%的患者在10岁时实现日间尿失禁,20岁后仅有1例仍有尿失禁。1例等待移植的转流患者膀胱小且收缩。最近对10例延迟尿失禁患者进行的尿动力学研究未显示膀胱顺应性或容量降低。对不同治疗结果的Kaplan-Meier分析表明,在终末期肾病发展时患者年龄无统计学差异。然而,比较不同治疗组的手术数量发现,转流婴儿的手术量显著增加。我们的结果与已发表的最佳系列研究结果相当,其中许多研究强烈主张高位转流术。
通过在大多数情况下避免转流,膀胱功能得以保留,膀胱扩大术的需求减少。